📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
20
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NAMS.
💹 Market Data
Market Cap$4.14B
Shares Outstanding116.90M
Float80.70M
Cash$636.11M
Debt$23.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 3.8% shares (2025Q4 vs prior)
185 institutional holders · 119.96M shares
#1
Frazier Life Sciences Management, L.P.
16.94M shares
#2
Capital World Investors
9.98M shares
#3
RA CAPITAL MANAGEMENT, L.P.
9.55M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest7.88M
Days to Cover8.9
% of Float9.8%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NAMS
📊 NAMS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NAMS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.